key: cord-0854886-xz31y8vb
authors: Nimir, Mohammed; Tank, Atisha; Snead, David
title: COVID-19 post-mortem findings: how the departed can teach us
date: 2021-07-29
journal: Diagn Histopathol (Oxf)
DOI: 10.1016/j.mpdhp.2021.07.003
sha: f1a695b7f74bc707d8822c970063b8e861f7f01c
doc_id: 854886
cord_uid: xz31y8vb

We present an asthmatic 39 year old female frontline healthcare worker in contact with COVID-19 patients, who suffered from respiratory problems for a few days, after which she was found dead by her spouse. Post-mortem (PM) examination showed lung consolidation and histological evidence of diffuse alveolar damage (DAD), in form of hyaline membrane disease, as well as atypical cells, thrombi and fibrin plugs inside pulmonary capillaries. Swab sample testing for SARS-CoV-2 confirmed the infection status. SARS-CoV-2 is a novel coronavirus which first emerged in Wuhan, China, and PM is contributing immensely to uncovering the pathophysiological mechanism of this disease. SARS-CoV-2 enters host cells via the angiotensin-converting enzyme 2 (ACE2), and can lead to a fatal pneumonia characterised histologically by DAD (the most consistent PM finding). This is due to invasion by the virus of type II pneumocytes, which leads to the death of both type I and II pneumocytes and increased capillary permeability. This compromises gas exchange which can lead eventually to cardiorespiratory failure and death.

The body was that of a young Asian female, in keeping with the stated age. On organ examination, the left lung weighed 531 grams and the right lung weighed 740 grams, and both lungs showed extensive consolidation, particularly in the lower lobes. There was widespread lymphadenopathy in the thoracic lymph nodes draining the lungs. There was no evidence of excess bronchial secretions or lung hyperexpansion and hence no macroscopic evidence of an asthma attack at the time of death. The other major internal organs showed no macroscopic abnormality.

Lung specimens were taken for histology, which showed evidence of diffuse alveolar damage, in form of hyaline membrane disease. Pulmonary oedema was noted, and atypical cells were seen in endothelial spaces. Furthermore, thrombi and fibrin plugs were seen inside pulmonary capillaries. Examination of a thoracic lymph node showed sinus expansion with blast-like lymphoid cells. Figure 1 demonstrates the histology findings mentioned.

Swabs were taken from the nose, throat, trachea and bronchi for PCR testing, which proved positive for SARS-CoV-2. As such, the cause of death was recorded as pneumonia due to SARS-CoV-2 (COVID-19) infection.

SARS-CoV-2 is a novel coronavirus which first emerged in Wuhan, China where it caused an outbreak of unusual pneumonia in December 2019 (1) . What is intriguing is how this disease can be fatal in a short span of time in otherwise relatively healthy and young individuals, as described in our case report. SARS-CoV-2 enters host cells via the angiotensin-converting enzyme 2 (ACE2), which leads to an initial localised infection where patients are asymptomatic and infective (2) . This progresses, in some individuals, to upper and lower respiratory tract infections, where the virus invades type II pneumocytes. This stimulates a cascade of inflammatory cytokines resulting in both type I and II pneumocyte apoptosis and increased capillary permeability (3) .

While in the majority of cases (80%) the acute immune host response is sufficient to clear infection (1), a group of patients develop severe to fatal disease in the form of diffuse alveolar damage (DAD) resulting clinically in acute respiratory distress syndrome (ARDS) (4). One study highlighted DAD as the most consistent lung finding in all deceased COVID-19 patients, accurately detailing the hallmark characteristics of DAD seen histologically (4).

DAD caused by SARS-CoV viruses occurs in two phases which can occur simultaneously in different areas of the lung parenchyma; this depends on whether the lung tissue is exhibiting an immune response to the virus (acute phase) or if its organising to a reparative end (organising phase) (3). The acute phase is caused either by a direct effect of viral life cycle (resulting in apoptosis of infected cells) or via 'cytokine storm' (1). It is characterised by the formation of hyaline membranes from fibrin polymerisation of the excess fluid within the alveoli and interstitium, as seen in our case. Intra-alveolar oedema and interstitial widening is also visualised, in addition to thrombin formation (4) . The organising phase is discerned by acute fibrinous organising pneumonia due to fibroblast proliferation. This is an attempt to repair the parenchyma in response to alveolar damage. The extensive tissue damage and remodelling can compromise gas exchange, and the deoxygenation can occur rapidly enough to lead to cardio-respiratory failure and death (2, 5) , as seen in our case.

To conclude, infection with SARS-CoV-2 can manifest on a clinical scale from asymptomatic to fatal disease. Post-mortem studies have been integral in determining the pathophysiological process of COVID-19 and the classical histopathological features of DAD are seen consistently in COVID-19 positive patients.

 Infection with SARS-CoV-2 can be fatal even in young and healthy individuals. 

COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment. Postgraduate medical journal

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. The Lancet Respiratory Medicine

Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians. Respiratory medicine

Histopathology features of the lung in COVID-19 patients

Clinical characteristics of coronavirus disease 2019 in China

What is the most consistent finding during post-mortem histological examination of COVID-19 patient samples?: A. Lung collapse B. Pulmonary embolism C. Diffuse alveolar damage D. Peri-vascular inflammatory infiltrate E